Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 101-125 of 1083 results.
{{ selectedCountPage }} items selected on this page,{{ selectedCountPage }} item selected on this page,{{ selectedCountTotal }} item in total{{ selectedCountTotal }} items in total
patients improved from Covid-19
Design:
This is a randomized clinical trial, in which 60 eligible patients (...) patients with Covid-19 referring to the Besat Hospital in Hamadan city during the study period will be (...) years;
Discharge after affected with Covid-19;
Exclusion criteria:
Cardiopulmonary diseases;
Any
Study aim:
comparison of improving cough in patients with covid-19 between gabapentin, gabapentin+montelukast, and dextromethorphan groups
Design:
Open-label randomized controlled clinical trial
Settings (...) - Covid-19 infection with any severity with the criteria of pulmonary involvement in CT scan of the lung
, hydroxychloroquine in outpatients with Covid19
Design:
Patients were treated with a treatment strategy after a (...) procedure of treatment of patient patients were followed.
Settings and conduct:
Patients with Covid19(...) /Inclusion and exclusion criteria:
inclusion:
Patients with Covid19 coincide with disease confirmation
years male patients with COVID-19 pneumonia
Design:
Phase 3 double-blind randomized controlled (...) numbers of KitSet.
Settings and conduct:
prescription of finastride in 80 patients with COVID-19(...) criteria:
males with coronavirus pneumonia over 50 years old
No entry: use of finasterid before covid-19
Study aim:
Evaluation of convalescent plasma therapy in the treatment of patients with COVID-19(...) . Convalescent plasma will be received from those recovering from COVID-19 disease previously hospitalized at (...) infused to the patients with confirmed infection of COVID-19.
Participants/Inclusion and exclusion
patients with COVID-19
Design:
A randomized, nonblinded, two-arm, parallel-group, phase 3 controlled trial (...) with COVID-19
Participants/Inclusion and exclusion criteria:
Inclusion criteria: Hospitalized patients with COVID- 19; patients who own a smartphone; patients who have the ability to work with a smartphone
in patients with COVID-19
Design:
The randomized clinical trial, parallel groups, 23 patients will (...) be prescribed standard regimen for COVID-19. Patients in intervention group in addition to the (...) weeks.
Participants/Inclusion and exclusion criteria:
The confirmed COVID-19 patients through PCR over
Study aim:
The purpose of this study will to evaluate the role of regional hyperthermia of the chest wall on the oxygen saturation of Covid-19 patiens who suffer from lung disorders as a result of this disease to find a way inactivate covid-19 viruses.
Design:
َAfter using hyperthermia for the
patients with Covid-19 disease.
Design:
A non-control clinical trial will be performed on 100 patients with Covid19 which are hospitalized. This study is not randomized and exercise therapy will be (...)Covid-19 disease with arterial oxygen saturation below 90% who require hospitalization.
Intervention
standard regimen for COVID-19. The intervention group will be prescribed fingolimod 50 mg oral one time daily for three days and standard regimen for COVID-19.-19. The routine lab data blood cell count, CT (...) :
Control group: will receive a standard regimen for COVID-19.
Intervention group: will receive a standard
COVID19 patients.
Design:
The randomized clinical trial with two parallel groups; without blinding, in (...) protocol for COVID-19.
Disease duration, the mortality rate, and the rate of symptom improvement at the 5th (...) years old
-Both Sexes
-COVID-19 patients based on clinical manifestations
or according to CBC, CRP
Study aim:
Comparison of safety and efficacy of recombinant spike protein COVID-19 vaccine (...) and smart phone; No current COVID -19; Non pregnant (women); Signed informed
consent. Exclusion (...) medical or surgical care; Breastfeeding; received any type of COVID-19 vaccine; History of sever allergic
Study aim:
Assessing the effect of the BCG vaccine on preventing COVID-19 infection in healthcare (...) the COVID-19 hospitals in Shiraz, Iran. Participants will be follow-up for 12 months with regular mobile phone text messages to identify COVID-19 infection and related issues.Blood samples will be
-Efficacy in Patients With COVID-19
Design:
This is a randomized clinical trial study that will be performed on 60 patients with covid-19 and patient caregivers.
Settings and conduct:
Using easily available sampling, we sample all patients with covid-19 and their family caregivers who have been admitted and
Study aim:
Assess the effect of digital-based educational intervention about COVID-19 using (...) educational program about COVID-19 were excluded from the study.
Intervention groups:
Digital-based (...) -protective behaviors regarding COVID-19
Study aim:
Using COVID-19 convalescent plasma for the purpose of passive immunization in current COVID-19 pandemic
Design:
Single arm, open label, clinical trial employing WHO recognized monitored (...) exclusion criteria:
Inclusion Criteria: informed consent must have been obtained, confirmed COVID-19 cases
laboratory signs of Iranian COVID-19 patients
Design:
This study is a two arm parallel group, double blinded clinical trial in phase 2 which will be carried out on 40 hospitalized COVID-19 patients (...) hospitalized COVID-19 patients in Shariati and Imam Khomeini hospitals will be included in this study
Study aim:
Evaluation of Fenofibrate effect on the prognosis in hospitalized patients with COVID-19(...) 69 admitted patients following COVID-19 using the simple randomization method.
Settings and conduct (...) national management protocol for COVID-19 patients. Using the simple randomization method, numbers from 1
the severity of COVID-19 in patients with mild to moderate COVID-19
Design:
Randomized double blind (...) .
Participants/Inclusion and exclusion criteria:
Inclusion criteria:
Positive test for COVID-19 according to World Health Organization criteria and diagnosed with COVID-19 of mild to moderate severity
Willingness
Study aim:
Evaluation the effect of Linagliptin on the outcome of COVID-19 in diabetic patients (...) with definite diagnosis of COVID-19 with PCR, hospitalized in Allameh Boohlol Gonabadi Hospital (...)COVID-19 with PCR, Disease severity of mild to moderate.
Exclusion criteria:Lack of interest to
Study aim:
Comparison of the therapeutic effect of Favipiravir with Standard medication in COVID-19(...) study was performed on patients with moderate COVID-19 referred to the infectious diseases clinic of (...) .
Participants/Inclusion and exclusion criteria:
Inclusion criteria are: Laboratory confirmation of COVID-19
Study aim:
Identifying the role of plasma cluster in the alleviation of symptoms in Covid-19(...) is included in the clinical investigation.
Settings and conduct:
Outpatients with Covid-19 who do (...) as 16-hour Covid-19 testing centers.
Participants/Inclusion and exclusion criteria:
Patients with
Study aim:
Investigation of Anti-TNF-α (Infliximab) drug effectiveness in COVID-19 patients (...) than COVID19.
Intervention groups:
There are 2 intervention groups, including the group receiving the infliximab drug and the group receiving the placebo. Both groups of patients with Covid-19 have severe to
Study aim:
Evaluation to the effect of Montelukast on treatment of the patients with COVID-19 infection.
Design:
This is a clinical trial in phase 3 in which the patients with diagnosis of COVID-19(...) admitted in collegiate hospitals, in Iran- Isfahan and the patients with COVID-19 will be enrolled in this
status in patients with COVID-19
Design:
This study is a double-blind randomized controlled clinical (...) exclusion criteria:
We will invite 44 patients with COVID-19 to enter the study based on inclusion and exclusion criteria.
Inclusion criteria:
1. Being 20 to 60 years old
2. Detection of COVID-19 based on PCR